OPKO Health, Inc. Common Stock OPK
HEALTHCARE · DIAGNOSTICS & RESEARCHi
Market dataready · fetched 2026-11-12T02:41:22.146Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:55:57.906934917Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-12T02:41:21.760196+00:00
OPKO Health, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.99 | 99.5% | 17.4% | 1.12 | 480.0% | 45.2% |
| 25Δ | 1.95 | 99.9% | 16.1% | 1.23 | 447.5% | 40.7% |
| 30Δ | 1.91 | 100.2% | 14.9% | 1.33 | 415.0% | 36.1% |
| 35Δ | 1.87 | 100.5% | 13.6% | 1.43 | 382.5% | 31.6% |
| 40Δ | 1.83 | 100.8% | 12.4% | 1.54 | 350.0% | 27.1% |
| 45Δ | 1.79 | 101.2% | 11.1% | 1.64 | 317.6% | 22.5% |
| 50Δ | 1.75 | 101.5% | 9.9% | 1.75 | 285.1% | 18.0% |
| 55Δ | 1.71 | 101.8% | 8.6% | 1.85 | 252.6% | 13.5% |
| 60Δ | 1.67 | 102.1% | 7.4% | 1.95 | 220.1% | 8.9% |
| 65Δ | 1.64 | 102.5% | 6.1% | 2.07 | 207.7% | 6.4% |
| 70Δ | 1.60 | 102.8% | 4.8% | 2.19 | 210.7% | 5.3% |
| 75Δ | 1.56 | 103.1% | 3.6% | 2.32 | 213.8% | 4.2% |
| 80Δ | 1.52 | 103.4% | 2.3% | 2.44 | 216.8% | 3.1% |
20Δ
- Pseudo strike
- 1.99
- IV
- 99.5%
- B/E move
- 17.4%
- Pseudo strike
- 1.12
- IV
- 480.0%
- B/E move
- 45.2%
25Δ
- Pseudo strike
- 1.95
- IV
- 99.9%
- B/E move
- 16.1%
- Pseudo strike
- 1.23
- IV
- 447.5%
- B/E move
- 40.7%
30Δ
- Pseudo strike
- 1.91
- IV
- 100.2%
- B/E move
- 14.9%
- Pseudo strike
- 1.33
- IV
- 415.0%
- B/E move
- 36.1%
35Δ
- Pseudo strike
- 1.87
- IV
- 100.5%
- B/E move
- 13.6%
- Pseudo strike
- 1.43
- IV
- 382.5%
- B/E move
- 31.6%
40Δ
- Pseudo strike
- 1.83
- IV
- 100.8%
- B/E move
- 12.4%
- Pseudo strike
- 1.54
- IV
- 350.0%
- B/E move
- 27.1%
45Δ
- Pseudo strike
- 1.79
- IV
- 101.2%
- B/E move
- 11.1%
- Pseudo strike
- 1.64
- IV
- 317.6%
- B/E move
- 22.5%
50Δ
- Pseudo strike
- 1.75
- IV
- 101.5%
- B/E move
- 9.9%
- Pseudo strike
- 1.75
- IV
- 285.1%
- B/E move
- 18.0%
55Δ
- Pseudo strike
- 1.71
- IV
- 101.8%
- B/E move
- 8.6%
- Pseudo strike
- 1.85
- IV
- 252.6%
- B/E move
- 13.5%
60Δ
- Pseudo strike
- 1.67
- IV
- 102.1%
- B/E move
- 7.4%
- Pseudo strike
- 1.95
- IV
- 220.1%
- B/E move
- 8.9%
65Δ
- Pseudo strike
- 1.64
- IV
- 102.5%
- B/E move
- 6.1%
- Pseudo strike
- 2.07
- IV
- 207.7%
- B/E move
- 6.4%
70Δ
- Pseudo strike
- 1.60
- IV
- 102.8%
- B/E move
- 4.8%
- Pseudo strike
- 2.19
- IV
- 210.7%
- B/E move
- 5.3%
75Δ
- Pseudo strike
- 1.56
- IV
- 103.1%
- B/E move
- 3.6%
- Pseudo strike
- 2.32
- IV
- 213.8%
- B/E move
- 4.2%
80Δ
- Pseudo strike
- 1.52
- IV
- 103.4%
- B/E move
- 2.3%
- Pseudo strike
- 2.44
- IV
- 216.8%
- B/E move
- 3.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 101.89% | |
| 94.26% | |
| 111.46% |
Diagnostics & Research
PSNL
Personalis, Inc. is a global cancer genomics company. The company is headquartered in Menlo Park, California.
More →QGEN
QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally. The company is headquartered in Venlo, the Netherlands.
More →RDNT
RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
More →RVTY
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets globally. The company is headquartered in Waltham,…
More →SHC
Description unavailable
More →TMO
Description unavailable
More →